Form 4 Tracker
Dominick Colangelo

Director; Director, President and CEO · 3 filings · Latest: Jun 3, 2026

Trevi Therapeutics, Inc.
Vericel Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VCEL
Dominick ColangeloDirector, President and CEOFeb 24, 2026
Option Exercise
$0.0018,250321,270
VCEL
Dominick ColangeloDirector, President and CEOFeb 24, 2026
Option Exercise
18,250303,020
VCEL
Dominick ColangeloDirector, President and CEOFeb 18, 2026
Option Exercise
$0.0011,700290,427
VCEL
Dominick ColangeloDirector, President and CEOFeb 18, 2026
Option Exercise
18,250278,727
VCEL
Colangelo DominickMay 15, 2025
Proposed Sale
$42.2614,063$594.3K
VCEL
Colangelo DominickMay 14, 2025
Proposed Sale
$43.2914,062$608.7K
VCEL
Colangelo DominickApr 10, 2025
Proposed Sale
$41.8924,850$1.0M
VCEL
Colangelo DominickApr 9, 2025
Proposed Sale
$41.1124,850$1.0M
VCEL
Colangelo DominickMar 13, 2025
Proposed Sale
$45.7826,592$1.2M
VCEL
Colangelo DominickMar 12, 2025
Proposed Sale
$46.3126,591$1.2M
VCEL
Colangelo DominickNov 14, 2024
Proposed Sale
$53.9317,500$943.8K
VCEL
Colangelo DominickNov 13, 2024
Proposed Sale
$55.5717,500$972.5K
VCEL
Colangelo DominickOct 17, 2024
Proposed Sale
$40.3417,500$706.0K
VCEL
Colangelo DominickOct 16, 2024
Proposed Sale
$41.3817,500$724.2K
VCEL
Colangelo DominickSep 12, 2024
Proposed Sale
$43.9017,500$768.3K
VCEL
Colangelo DominickSep 11, 2024
Proposed Sale
$43.3717,500$758.9K